The world is experiencing a hidden epidemic with kidney disease. More than 850 million people worldwide have some form of ...

Excalipoint Therapeutics closed an oversubscribed $68.7 million seed financing, one of the largest early-stage rounds for a Chinese biotechnology company, to advance its pipeline of six T-cell engager ...

UCSF scientists found a precise way to turn on cancer-fighting immune cells inside the body. This more potent form of CAR-T ...

Pulmonary arterial hypertension, or PAH, is a rare and severe disease characterized by elevated blood pressure in the ...

In this article, we will discuss the 13 Best Growth Stocks to Buy Right Now. On March 16, Chief Investment Strategist at Hightower Stephanie Link and Chief Investment Officer at NFJ Investment Group ...

OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and for inflammatory eye ...

Longevity and AI experts discuss the bottlenecks preventing AI-driven insights from becoming actionable clinical interventions.

The powerful gene-editing technique CRISPR–Cas9 might offer a way to make safer, more effective cancer-fighting immune cells ...

Cancer-fighting T cells do not simply "run out of energy." They are molecularly reprogrammed. For years, mitochondrial dysfunction has been recognized as a hallmark of exhausted T cells in tumors. Yet ...

Our limited understanding of the metabolism of our microbial ancestor is a sizeable gap in our knowledge of how complex life originated. Resolving whether our closest microbial relatives had ...

Imaging studies of more than 27,000 adults link a healthier thymus on CT scans with a longer life and lower risks of ...

A bandage-like microneedle patch can noninvasively collect immune cells and signals from the skin within minutes to hours. Early tests suggest it could transform how immune responses are monitored.